Shortlist by what you need
Start here if you know why you are leaving InformAI.
Want the closest match?
ArteraMost similar to InformAI in what it does, its category and its price.
Visit (opens Artera in a new tab)Want the best rated?
AZmedRated 4.4 out of 5 in our review, against 3.9 for InformAI.
Visit (opens AZmed in a new tab)
At a glance
Green means better than InformAI, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
 InformAIBaseline | 3.9 | Not listed | No | Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products. | |
| Artera | 4.4+0.5 | Not listed | No | FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. | vs InformAI |
 Rayscape | 3.7−0.2 | Not listed | No | FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm. | vs InformAI |
 InHEART | 4.2+0.3 | Not listed | No | InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk. | vs InformAI |
 PathAI | 4.3+0.4 | Not listed | No | First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp | vs InformAI |
 Proscia | 4.3+0.4 | Not listed | No | FDA-cleared digital pathology platform for primary diagnosis and biomarker research. | vs InformAI |
| AZmed | 4.4+0.5 | Not listed | No | FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays. | vs InformAI |
 AI Optics | 4.0+0.1 | Not listed | No | Portable, FDA-cleared retinal camera pairing proprietary optics with on-device AI screening. | vs InformAI |
 Oatmeal Health | 3.3−0.6 | Not listed | No | AI reads 3D low-dose CT scans and risk-stratifies lung nodules (AUROC 0.94, trained on 100,000+ scans) - already deployed across underserved health centers in 4 states. | vs InformAI |
The alternatives in detail
In order of how closely each one matches InformAI.
Artera
4.4Not listed
vs InformAI+0.5
FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions.
- Multimodal AI trained on digitized biopsy images paired with clinical data
- FDA De Novo authorization for the ArteraAI Prostate Test
- FDA clearance for ArteraAI Breast digital pathology risk stratification
Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups
Not a self-serve software product; access runs through labs, clinicians, and insurance billing
Rayscape
3.7Not listed
vs InformAI−0.2
FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm.
- 148+ pathology detection on chest X-rays
- Pulmonary nodule detection, measurement, and tracking on lung CT
- Multiple FDA clearances and extensive clinical validation
Genuine regulatory clearance (FDA) rather than just a marketing claim
Pricing isn't public - requires direct institutional engagement
InHEART
4.2Not listed
vs InformAI+0.3
InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk.
- AI segmentation of CT and MRI scans into interactive 3D heart models
- 24-hour turnaround from scan submission to delivered model
- FDA 510(k)-cleared AI software for cardiac image segmentation
FDA 510(k) clearance gives the AI segmentation regulatory credibility beyond a research tool
No public pricing; adoption requires a hospital procurement and contracting process
PathAI
4.3Not listed
vs InformAI+0.4
First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp.
- AISight Dx analyzes digital pathology slide images to assist diagnosis
- FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
- Predetermined Change Control Plan allows faster future software updates
Genuine FDA clearance for primary diagnosis, not just an assistive tool
Enterprise quote-based pricing requires a sales conversation, no published rates
Proscia
4.3Not listed
vs InformAI+0.4
FDA-cleared digital pathology platform for primary diagnosis and biomarker research.
- FDA-cleared for primary clinical diagnosis in AP-Dx
- Concentriq AP, AP-Dx and LS configurations
- Biomarker research and clinical trial workflows
FDA clearance for primary diagnosis, not just research viewing
No published pricing
AZmed
4.4Not listed
vs InformAI+0.5
FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays.
- FDA-cleared fracture, joint effusion, and dislocation detection (AZtrauma)
- FDA-cleared chest X-ray triage for nodules, pneumothorax, and pleural effusion (AZchest)
- Pediatric and adult population coverage
Multiple FDA clearances rather than a single narrow approval
No public pricing; only reachable through a sales demo
AI Optics
4.0Not listed
vs InformAI+0.1
Portable, FDA-cleared retinal camera pairing proprietary optics with on-device AI screening.
- Handheld, rechargeable fundus camera
- On-device AI screening for diabetic retinopathy, AMD, and glaucoma
- No pupil dilation required for imaging
FDA clearance backs the device for clinical use
Requires purchasing dedicated hardware, not software-only
Oatmeal Health
3.3Not listed
vs InformAI−0.6
AI reads 3D low-dose CT scans and risk-stratifies lung nodules (AUROC 0.94, trained on 100,000+ scans) - already deployed across underserved health centers in 4 states.
- AI risk-stratification of lung nodules from 3D low-dose CT
- AUROC 0.94, trained on 100,000+ CT scans
- Complements established Lung-RADS protocols
Real, verifiable clinical deployment, not just a pilot announcement
LungAI is an investigational device and has not yet been cleared by the FDA - a 510(k) submission is targeted for Q1 2026
FAQ
Questions people ask
Is InformAI free?
InformAI does not list a free plan. Check its pricing page for current plans.
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.